Stephen Born is the Co-Founder and Senior Director, Head of Scientific Affairs for Continuus Pharmaceuticals. After obtaining a PhD in organic chemistry from the University of California, San Diego, he pursued a postdoc at MIT with Prof. Klaus Jensen in the Department of Chemical Engineering.  In the Novartis-MIT Center for Continuous Manufacturing, his flow chemistry and separations experience contributed to the success of the first integrated end-to-end demonstration for the continuous synthesis, purification, isolation, formulation, and tableting of a Novartis drug. 

In his current role, Stephen manages technical strategy by focusing on breakthrough innovation in the industry, collaborating with external partners, and proactively driving internal development programs. His pastimes include understanding how to bias equilibrium-driven processes, cooking, designing closed-loop process automation, and running long distances.